XBIT logo
XBIT NASDAQ US

XBiotech Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Apr 2015
$2.35
▲ +$0.01 (+0.43%)
Vol 6K
3
Quality Score
fail
Mkt Cap
$72.9M
ROE
-17.0%
Margin
-820.5%
D/E
0.00
Beta
0.87
52W
$2–$5

Wall Street Consensus

7 analysts · Dec 2021
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Similar Stocks

EXOZ
eXoZymes Inc
$91.4M
PMVP
PMV Pharmaceuticals Inc
$66.5M
BYSI
Beyondspring Inc
$67.0M
MNOV
MediciNova Inc
$64.4M
DWTX
Dogwood Therapeutics Inc
$123.7M
CYPH
Cypherpunk Technologies Inc
$65.7M
IBIO
iBio Inc
$43.4M
ACET
Adicet Bio Inc
$80.7M

Earnings

Beat rate: 50.0%
Next Report May 12, 2026
Quarter EPS Est EPS Act Surprise
Mar 2026 — — —
Mar 2020 $0.06 $0.00 $-0.06
Dec 2019 $-0.15 $14.59 +$14.74
Sep 2019 $-0.15 $-0.15 +$0.00

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -15.9% -21.1% -15.6% -15.6% -15.6% -17.0%
P/E (TTM) — — — — — —
Net Margin — -820.5% -820.5% -820.5% -820.5% -820.5%
Gross Margin — 83.8% 83.8% 83.8% 83.8% 83.8%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 40.16 29.15 40.16 40.16 40.16 41.78

Key Ratios

ROA (TTM)
-16.2%
P/S (TTM)
18.17
P/B
0.7
EPS (TTM)
$-0.98
52W High
$4.67
52W Low
$2.09
$2.09 52-Week Range $4.67

How does XBIT compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

XBIT AAPG ABEO ABOS ABP

XBIT valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
18.2
▲ 41% above peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
0.7
▼ 73% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

XBIT profitability vs Biotechnology peers

ROE
-17.0%
▲ 75% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-820.5%
▼ 186% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
83.8%
▲ 7% above peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-16.2%
▲ 65% above peers (-46.7%)
vs Peers
vs Industry
Top tier

XBIT financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
41.8
▲ 841% above peers (4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.9
▼ 10% below peers (1.0)
vs Peers
vs Industry
Less volatile

XBIT fundamentals radar

XBIT Peer median Industry

XBIT profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

XBIT vs peers: key metrics

Latest News

No related news yet